← 產業報告目錄
Multi Cancer Early Detection Market Size, Share & Trends Analysis Report By Type (Liquid Biopsy, Gene Panel, LDT and Others), By End-Use (Hospitals, Diagnostic Laboratories, Others), By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-23頁數 185報告編號 INSIGHTACE-035851394e
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Multi Cancer Early Detection Market is positioned for steady expansion, with a projected CAGR of 16.8% from 2025 to 2034.
Multi Cancer Early Detection encompasses key industry insights & findings from the report:
The surging cases of various types of cancer globally is driving the demand for early detection methods. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Growth is bolstered by a convergence of factors: rising awareness among end users, continuous product innovation, and the surging emphasis on efficiency and sustainability within the healthcare sector.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, bolstered by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Multi Cancer Early Detection Market Snapshot
Chapter 4. Global Multi Cancer Early Detection Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn) & Volume (no. of units) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product Type:
5.2.1. Liquid Biopsy
5.2.2. Gene Panel, LDT and Others
Chapter 6. Market Segmentation 2: by End-users Estimates & Trend Analysis
6.1. by End-users & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn) & Volume (no. of units) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-users:
6.2.1. Hospitals
6.2.2. Diagnostic Laboratories
6.2.3. Others
Chapter 7. Multi Cancer Early Detection Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Multi Cancer Early Detection Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
7.1.2. North America Multi Cancer Early Detection Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2021-2034
7.1.3. North America Multi Cancer Early Detection Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.2. Europe
7.2.1. Europe Multi Cancer Early Detection Market revenue (US$ Million) by Product Type, 2021-2034
7.2.2. Europe Multi Cancer Early Detection Market revenue (US$ Million) by End-users, 2021-2034
7.2.3. Europe Multi Cancer Early Detection Market revenue (US$ Million) by country, 2021-2034
7.3. Asia Pacific
7.3.1. Asia Pacific Multi Cancer Early Detection Market revenue (US$ Million) by Product Type, 2021-2034
7.3.2. Asia Pacific Multi Cancer Early Detection Market revenue (US$ Million) by End-users, 2021-2034
7.3.3. Asia Pacific Multi Cancer Early Detection Market revenue (US$ Million) by country, 2021-2034
7.4. Latin America
7.4.1. Latin America Multi Cancer Early Detection Market revenue (US$ Million) by Product Type, 2021-2034
7.4.2. Latin America Multi Cancer Early Detection Market revenue (US$ Million) by End-users, 2021-2034
7.4.3. Latin America Multi Cancer Early Detection Market revenue (US$ Million) by country, 2021-2034
7.5. Middle East & Africa
7.5.1. Middle East & Africa Multi Cancer Early Detection Market revenue (US$ Million) by Product Type, 2021-2034
7.5.2. Middle East & Africa Multi Cancer Early Detection Market revenue (US$ Million) by End-users, 2021-2034
7.5.3. Middle East & Africa Multi Cancer Early Detection Market revenue (US$ Million) by country, 2021-2034
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1 Micronoma Inc
8.2.2 Anpac Bio
8.2.3 EarlyDiagnostics, Inc
8.2.4 Early is Good (EIG)
8.2.5 Cansense
8.2.6 Freenome Holdings, Inc.
8.2.7. Oncocyte Corporation
8.2.8 SeekIn
8.2.9 Naveris
8.2.10 VESEN, Inc.
8.2.11 Grail, LLC (Illumina, Inc.)
8.2.12 Exact Sciences Corporation
8.2.13 Foundation Medicine, Inc.
8.2.14 AnchorDx
8.2.15 Guardant Health, Inc.
8.2.16 Burning Rock Biotech Limited
8.2.17 GENECAST
8.2.18 Laboratory for Advanced Medicine, Inc.
8.2.19 Singlera Genomics Inc.
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們